|
|
General
|
| |
Clinical Use:
|
This is a semiquantitative assay for eliminating sulphonylurea ingestion in cases of unexplained hypoglycaemia.
The oral hypoglycaemic screen is able to detect 6 sulphonylurea drugs.
The screen is only reliable for specimens collected within 24 hours of drug ingestion.
|
| |
Availability:
|
Samples are batched and tested fortnightly.
Results are released three weeks post specimen receipt at the testing laboratory. |
| |
Aliases/Synonyms:
| Chlorpropamide, Glibenclamide, Gliclazide, Glipizide, Oral Hypoglycaemic Screen , Tolazamide, Tolbutamide, |
| |
Code:
|
SUS |
| |
Handling Instructions (to laboratory):
|
Send sample chilled. |
| |
Hyperlink:
|
|
| |
Reference Interval:
|
Refer to report or laboratory
|
Collection Requirements
|
| |
Container:
|
Serum Sep. Tube-SST (GOLD), |
| |
Sample Type:
|
See container |
| |
Minimum Collection Volume:
|
4mL |
| |
Collection Instructions:
|
|
Processing Requirements
|
| |
Alternate Containers:
|
|
| |
Processing Instructions:
|
Centrifuge, separate and freeze sample. |
| |
Minimum Assay Volume:
|
1mL |
| |
Stability:
|
|
| |
Transport Instructions (to testing laboratory):
|
Send separated sample frozen on dry ice. |
Testing Locations
|
| |
Performed at:
|
|
Section
|
Department
|
Site
|
Contact Phone
|
| - |
Laboratory |
Melbourne Health Shared Pathology Service |
(03) 9342 8000 |
|
Last Updated : 31-12-2025 10:07 |